LONDON, November 30 /PRNewswire/ -- ApaTech, the rapidly growing orthobiologics company, was named Europe's fastest growing Biotech/Pharmaceutical/Medical Technology/Equipment company in the Deloitte 2009 Technology Fast 500 for EMEA (Europe, Middle East and Africa).
This annual ranking is based on a companies' five-year revenue growth, for which ApaTech has achieved a rate of 8,318% over this period. This achievement places ApaTech 9th overall in the ranking that includes the fastest growing public and private technology, media, telecommunications, life sciences and green technology companies from 26 countries in EMEA.
Simon Cartmell, ApaTech CEO commented: "This award demonstrates that a great product based on great technology, with a great team behind it can achieve incredible results. The determination to succeed is embedded in the fabric of our business and the people that work here; their passion and ambition are the reason for our success."
"Because Deloitte Technology Fast 500 EMEA measures sustained revenue growth over five years, being one of the 500 fastest growing technology companies in EMEA is an impressive achievement," said David Halstead, partner in charge of Deloitte's Technology Fast 500 EMEA program. "ApaTech deserves a lot of credit for its remarkable growth."
The Deloitte Technology Fast 500 is the most objective industry-ranking standard to focus on the technology sector. Entrants to the ranking must have been in business at least five years and have had base-year operating revenues of at least EUR50,000 and current year operating revenues of at least EUR800,000.
ApaTech is the developer and manufacturer of Actifuse(R), a unique fully synthetic silicate substituted calcium phosphate bone graft material for orthopaedic, spinal, dental and craniomaxillofacial applications. The Actifuse scaffold mimics the body's natural bony structure and accelerates the growth of high quality bone. Actifuse is being used by surgeons in more than 30 countries around the world.
Notes to Editors:
ApaTech is a company specializing in synthetic bone repair materials for orthopedic and dental applications. With operations in London, England, Foxborough, Massachusetts, USA, and Berlin, Germany, ApaTech is a world leader in research and development of bone graft technologies. The company has enjoyed strong commercial success globally with products sold in 33 countries.
ApaTech has developed and commercialized a novel silicate substituted calcium phosphate bone graft material, Actifuse(R). Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The Actifuse technology platform exemplifies the Company's leadership in applying the science of silicon to bone graft technologies. ApaTech is backed by international investors Encore Ventures and Healthcor and following its formation in 2001, the Company has raised more than $60m from investors.
ApaTech is committed to delivering shareholder value by using its scientific leadership to deliver targeted solutions to physicians, allowing them to significantly improve patient outcomes.
ApaTech has received several corporate business and research awards, including the Frost & Sullivan '2009 North American Device Biologics Company of the Year' as a result of its success in the US orthobiologics market. More recently, ApaTech was awarded 3rd place in the UK Deloitte Technology Fast 50 (2009), in addition to being recognized as Britain's fastest growing medical technology company 3 years running in 2009, 2008 and 2007 by the Sunday Times Fast Track 100 fastest growing private technology companies review.
More details can be found at http://www.apatech.com
"Deloitte" is the brand under which tens of thousands of dedicated professionals in independent firms throughout the world collaborate to provide audit, consulting, financial advisory, risk management and tax services to selected clients. These firms are members of Deloitte Touche Tohmatsu, a Swiss Verein ("DTT"). Each member firm provides services in a particular geographic area and is subject to the laws and professional regulations of the particular country or countries in which it operates. DTT helps coordinate the activities of the member firms but does not itself provide services to clients. DTT and the member firms are separate and distinct legal entities, which cannot obligate the other entities. DTT and each DTT member firm are only liable for their own acts or omissions, and not those of each other. Each DTT Member Firm is structured differently in accordance with national laws, regulations, customary practice and other factors, and may secure the provision of professional services in their territories through subsidiaries, affiliates and/or other entities.
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss Verein, and its network of member firms, each of which is a legally separate and independent entity. Please see http://www.deloitte.com/about for a detailed description of the legal structure of Deloitte Touche Tohmatsu and its Member Firms.
CONTACT: Further Information: ApaTech, Simon Cartmell, CEO
+44-20-8731-4640, email@example.com, http://www.apatech.com;
Waughton, Robin Hepburn +44-20-7796-9999, firstname.lastname@example.org,